middle.news
How Will Nyrada’s Xolatryp Perform in Upcoming Heart Attack Trial?
1:01pm on Tuesday 21st of October, 2025 AEDT
•
Biotechnology
Read Story
How Will Nyrada’s Xolatryp Perform in Upcoming Heart Attack Trial?
1:01pm on Tuesday 21st of October, 2025 AEDT
Key Points
Phase I trial confirms strong safety profile for Xolatryp
Phase IIa trial planned for STEMI patients undergoing PCI
AU$8.25 million capital raised to support clinical and R&D activities
Collaborative study reinforces Xolatryp’s mitochondrial protective mechanism
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE